No Prescription |
 |
 | ||
|
Synermox Augmentin |
|
| ||
No Prescription » Prescription Drugs 15 » Synermox Augmentin Medical Information:Amoxicillin/clavulanic acid is a penicillin-type antibiotic used to treat a wide variety of bacterial infections. It works by stopping the growth of bacteria.This antibiotic only treats bacterial infections. It will not work for viral infections (e.g. common cold flu). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.How to use Amoxicillin/clavulanic acid OralTake this medication by mouth with a meal or snack usually every 8 or 12 hours or as directed by your doctor.Antibiotics work best when the amount of medicine in your body is kept at a constant level. Therefore take this drug at evenly spaced intervals.Continue to take this medication until the full prescribed amount is finished even if symptoms disappear after a few days. Stopping the medication too early may allow bacteria to continue to grow which may result in a relapse of the infection.Inform your doctor if your condition persists or worsens.Amoxicillin/clavulanic acid Oral is used to treat the following:Infection of the Middle Ear by H. Influenzae Bacteria Middle Ear Infection caused by Moraxella Catarrhalis Middle Ear Infection Acute Bacterial Infection of the Sinuses Severe Sinusitis caused by Haemophilus Influenzae Severe Sinusitis caused by Moraxella Catarrhalis Bacterial Pneumonia caused by Haemophilus Influenzae Pneumonia caused by the Bacteria Moraxella Catarrhalis Pneumonia caused by Bacteria Urinary Tract Infection Infection of Urinary Tract due to Enterobacter Cloacae Urinary Tract Infection due to E. Coli Bacteria Urinary Tract Infection caused by Klebsiella Bacteria Skin Infection Skin Infection due to Staphylococcus Aureus Bacteria Skin Infection due to E. Coli Bacteria Skin Infection due to Klebsiella BacteriaAmoxicillin/clavulanic acid Oral may also be used to treat:Highly Infectious Venereal or Sexually Transmitted Ulcer Presumed Infection in Febrile Neutropenic Patient Bacterial Infection with Chronic Bronchitis Diverticulitis Infection of the Biliary Tract Diabetic Foot Infection Pediatric Fever without a Source Dog Bite Wound Cat Bite Wound Human Bite Wound Buy Synermox Augmentin and other Prescription Drugs 15 products online at Medstore. Buy Online at Medstore - Click Here!
About Synermox Augmentin: Product Type: Prescription Drugs 15 Synermox ( Augmentin Generic Amoxicillin trihidrate/Potassium Clavulanate ) Synermox (Augmentin Generic Amoxicillin trihidrate/Potassium Clavulanate) Augmentin Generic Amoxicillin trihidrate/Potassium Clavulanate 500/125mg Augmentin Generic Amoxicillin trihidrate/Potassium Clavulanate Synermox
View more Prescription Drugs 15 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
